A Cross-sectional Study of the Impact of Blood Selenium on Blood and Urinary Arsenic Concentrations in Bangladesh

  • Christine Marie George1Email author,

    Affiliated with

    • Mary Gamble2,

      Affiliated with

      • Vesna Slavkovich3,

        Affiliated with

        • Diane Levy4,

          Affiliated with

          • Alauddin Ahmed5,

            Affiliated with

            • Habibul Ahsan6 and

              Affiliated with

              • Joseph Graziano2

                Affiliated with

                Environmental Health201312:52

                DOI: 10.1186/1476-069X-12-52

                Received: 29 April 2013

                Accepted: 21 June 2013

                Published: 1 July 2013

                Abstract

                Background

                Arsenic can naturally occur in the groundwater without an anthropogenic source of contamination. In Bangladesh over 50 million people are exposed to naturally occurring arsenic concentrations exceeding the World Health Organization’s guideline of 10 μg/L. Selenium and arsenic have been shown to facilitate the excretion of each other in bile. Recent evidence suggests that selenium may play a role in arsenic elimination by forming a selenium-arsenic conjugate in the liver before excretion into the bile.

                Methods

                A cross-sectional study of 1601 adults and 287 children was conducted to assess the relationship between blood selenium and urinary and blood arsenic in a study population residing in a moderately arsenic-contaminated rural area in Bangladesh.

                Results

                The results of this study indicate a statistically significant inverse relationship between blood selenium and urinary arsenic concentrations in both adult and pediatric populations in rural Bangladesh after adjustment for age, sex, Body Mass Index, plasma folate and B12 (in children), and ever smoking and current betel nut use (in adults). In addition, there appears to be a statistically significant inverse relationship between blood selenium and blood arsenic in children.

                Conclusions

                Our results suggest that selenium is inversely associated with biomarkers of arsenic burden in both adults and children. These findings support the hypothesis that Se facilitates the biliary elimination of As, possibly via the putative formation of a Se-As conjugate using a glutathione complex. However, laboratory based studies are needed to provide further evidence to elucidate the presence of Se-As conjugate and its role in arsenic elimination in humans.

                Keywords

                Selenium Arsenic Bangladesh Pediatric populations

                Background

                Arsenic (As) can occur naturally in groundwater without an anthropogenic source of contamination. Groundwater pumped from approximately half of the roughly 10 million tubewells in Bangladesh do not meet the World Health Organization (WHO) guideline for As of 10 μg/L [1]. Many other countries around the world are also affected by elevated levels of As in drinking water including Chile, Mexico, Mongolia, Nepal, Vietnam, India, Taiwan, China, and the United States [2]. Exposure to elevated levels of inorganic As (As) is associated with cancers of the skin, bladder, and lung[35], developmental effects [6, 7], cardiovascular disease [8, 9], skin lesions [10, 11], and decreased intellectual function in children [7, 12, 13].

                In contrast, selenium (Se) is an essential mineral for human health which occurs in plants such as corn, wheat, and soybean. These selenocompounds include selenite, selenate, selenocystine, selenomethionine, selenohomocysteine, and Se-methylselenocysteine [14]. It is thought that selenate is reduced to selenite then to selenide by reduced glutathione [15]. Selenium is important for the reduction of hydrogen peroxide and damaging lipid and phospholipids into harmless products via the Se dependent enzyme, glutathione peroxidase (GPx) [16]. In addition to GPx other major groups of selenoproteins include include thioredoxin reductase, iodothyronine deiodinase,and selenoprotein P [17, 18].

                The maximum contaminant level (MCL) for Se specified by the Environmental Protection Agency is 0.05 mg/L [19]. Previous studies of individuals accidently ingesting toxic levels of Se containing products with a total dose ranging from 27 to 2387 mg had the following symptoms: nausea, vomiting, nail changes, hair loss, fatigue, breath smelling like garlic, diarrhea, and abdominal cramping [20]. In addition, in selenosis endemic areas of China studies have found disorders of the nervous system and paralysis [21, 22].

                The antagonistic relationship between As and Se was first report by Moxon in 1938 when he discovered that As protected against Se toxicity [23]. This effect has since been observed in rats, rabbits, dogs, swine, and cattle [24]. Studies have indicated that Se and As facilitate the excretion of each other in bile [25, 26]. A metabolic link between arsenite and selenite has been identified in the bile of rabbits injected with Se and As [27]. In vitro evidence suggests the potential for the formation of this Se-As conjugate using glutathione (GS) complex (GS2AsSe) in the liver which is excreted into bile [26]. Biliary excretion of As by this pathway would likely reduce the amount of As excreted in urine. However the existence of this conjugate in humans remains unknown. In addition, a study of rat kidney cells found that As and Se are concentrated and precipitated in the lysosomes of renal cells, forming an insoluble selenide (As2Se) that is eventually eliminated in the urine [28][15]. This could be another potential As removal pathway.

                A recent cross-sectional study in adults in Araihazar, Bangladesh found that plasma Se was inversely associated with urinary and blood As concentrations, and genomic DNA methylation [29]. Consistent with this finding a case-cohort study conducted at the same study site found that participants with higher blood Se concentrations had significantly lower urinary As concentrations. In addition, it was found that those with blood Se below average were consistently at a greater risk of skin lesions associated with their As exposure [30]. In contrast, a study in West Bengal found no difference in the blood Se concentration in those affected by skin lesion verses controls, however the As exposure of neither group was well characterized [31].

                A recent animal study found that dietary organselenium was effective in preventing As from entering the peripheral tissue of mice that ingested arsenite in drinking water [32]. A second animal study found that co-administration of sodium arsenite and selenite had a protective effect on liver enzyme activity, thiobarbituric acid reactive substances levels, as well on glutathione peroxidase and glutathione-S-transferase in comparison to As treated animals [33]. These animal studies provide promising evidence for the role of Se in reducing As induced oxidative stress and the body burden of As.

                A small clinical trial in Bangladesh has shown suggestive evidence that vitamin E and Se can slightly improve As induced skin lesions [2]. There has only been one small study published to date evaluating the impact of daily supplementation of Se on blood As concentrations in humans. However this study conducted in Inner Mongolia combined a Se supplementation trial with an “As free” drinking water intervention making it difficult to determine the actual effect of the supplementation component [34].

                The current study is the first evaluation of the relationship between As and Se in a pediatric population. The primary objective of this study is to test the hypothesis that blood Se is inversely associated with blood and urinary As concentrations in children and adults living in an As contaminated area of Bangladesh.

                Methods

                Adult population

                The data for the adult population in this study is from participants enrolled in the Health Effects of Arsenic Longitudinal Study (HEALS). HEALS is an ongoing prospective cohort study in Araihazar, Bangladesh of 20,000 men and women ages 18–65 years old that started in the year 2000. The study area of the cohort contains a wide range of well water As concentrations. Baseline health information was collected from study participants as well as whole blood, urine, well water samples, a semi quantitative food frequency questionnaire to measure dietary intakes, and an extensive physical exam. The cohort is followed up at roughly two year intervals. The primary objective of this study is to investigate the health effects of As exposure from drinking water on individual level exposures. The study area is located in Araihazar upazilla which is a subdistrict, one of 507 upazillas located in Bangladesh. Araihazar has an area of 183 square kilometers and contains 12 unions [35]. In 2006–7, roughly 8,000 additional participants were recruited into the HEALS study. For the current study, we included a random sample of 1601 of these additional participants for analysis, using a random number generator. The average duration of use of wells for HEALS cohort participants is 10 and 8.3 years for males and females, respectively.

                Pediatric population

                The pediatric population in this study are children 8–11 years old living in the HEALS cohort study area who were enrolled in a cross-sectional study designed to assess the relationship between As and manganese(Mn) exposure and cognitive and motor function in children. This study recruited 301 children in the following four group based on their well-water concentrations: high As-high Mn (As > 10 μg/L and Mn > 500 μg/L); high As-low Mn; low As-high Mn; and low As-low Mn. Children were recruited between January and December 2008. Details on complete enrollment procedures have been previously published [7]. Only 287 of these children had blood Se information available, and thus included in the present study.

                Laboratory methods

                Blood samples were collected by venipuncture in Ethyl-enediaminetertraacetic acid (EDTA) containing Vacutainers tubes. These were placed in cool packs which were designed to keep blood samples at 0 degrees Celsius. Samples were transported within 6 hours to our local laboratory in Araihazar, Bangladesh to be stored at −80 Celsius. Samples were then shipped on dry ice to Columbia University for analysis. Urine samples were collected in 50 ml acid washed polypropylene tubes, and kept in portable coolers. Within 6 hours all urine samples were frozen at −20 degrees Celsius, and then shipped to Columbia University on dry ice.

                Blood arsenic and selenium

                Whole blood samples were analyzed for As and Se concentrations using a Perkin-Elmer Elan DRC II Inductively Coupled Plasma Mass Spectrometry (ICP-MS) equipped with AS 93+ autosampler. Matrix induced interferences were corrected for using internal standards. Whole blood samples were thawed and diluted with 1%HNO3 + 1% Methanol + 0.2% Triton X-100 + 0.5% NH4OH. Samples were then centrifuged for 10 minutes at 3500 rpm [36]. Our laboratory participates in a quality control program for blood As, and Se which is coordinated by the Institut de Santé Publique du Québec (Québec, Canada).

                Plasma folate and vitamin B-12

                Plasma folate and total cobalamin were measured by radioimmunoassay using the Quantaphase II radioimmunassay (Rad Laboratories, Richmond, CA). This method is performed by heating the sample to 100 degrees Celsius to denature endogenous binding substances. For the determination of folate, pteroylgutamic acid was used for calibration, and 125I-labeled analog was used as the tracer. For the determination of cobalamin, cyanocobalamin was used for calibration, and 57Co-labeled analogy was used as the tracer [37].

                Total urinary arsenic

                Total urinary As was measured using a Perkin-Elmer AAnalyst 600 graphite furnace system, and adjusted for urinary creatinine (Cr) concentrations according to pub-lished methods [38]. Our laboratory participates in a quality control program for total urinary As which is coordinated by the Institut de Santé Publique du Québec (Québec, Canada).

                Water arsenic

                Water As samples were collected in 20 ml acid-washed tubes and As concentrations were measured using Inductively Coupled Plasma-Mass Spectrometry with a detection limit of 0.1 μg/L at the Geochemistry Research Laboratory at Lamont Doherty Observatory (LDEO) at Columbia University [39].

                Statistical analysis

                The primary hypothesis of this study is that As exposure is inversely associated with Se status. The primary outcome variables in this study are blood and urinary As concentrations. The main predictor of interest is blood Se, and study covariates are age, sex, BMI, plasma folate and B12 (in children), ever smoking (for adults), current betel nut use (for adults), and urinary creatinine. We selected these covariates because they are known to influence As metabolism [29, 40, 41]. Plasma folate and B12 data were collected as part of the larger study of As and manganese exposure and cognitive and motor function in children. Unfortunately, plasma was not available for adults enrolled in HEALS study therefore we lack data on plasma folate and B12 in the adult population.

                Descriptive statistics were calculated for the general characteristics of the study population, and for relevant micronutrients and urinary and blood As concentrations. We examined bivariate associations between micronutrients in blood, blood and urinary As, and population characteristics using Spearman correlation coefficients.

                Blood and urinary As and blood Se were treated as continuous variables. Linear regression was used to examine the association between outcome variables and blood Se. All variables that were not normally distributed were log transformed. Blood Se values were also divided into five categories and covariate adjusted means were calculated. All analyses were performed using SAS, version 9.3 (SAS Institute Inc., Cary, NC, USA).

                Ethical approval and Consent

                Written Informed consent and child assent were obtained from study participants by trained field physicians. This study was approved by the institutional review boards of Columbia Presbyterian Medical Center and the Bangladesh Medical Research Council.

                Results

                Adult population

                The general characteristics of the 1601 adult participants are outlined in Table 1. The water As exposure in this population was low to moderate. The mean water As concentration was 52 μg/L. The mean age was 37 years and 62% of the study population was female. The average BMI was 19.7. Betel nut was currently used by 29% of the study population, and current cigarette use was 7%. Household landownership was 47%. The blood and urinary As concentrations in the population was 7 μg/L and 90 μg/L, respectively. Using Spearman correlation coefficients, blood Se was significantly associated with urinary creatinine (r = 0.09, p < 0.05), urinary As per gram creatinine (r = −0.08, p < 0.05), age (r = −0.10, p < 0.0001), and BMI (r = 0.10, p < 0.0001) (Table 2).
                Table 1

                General characteristics of the study population a

                 

                Mean±SD (range) or percent

                 

                Variable

                Adult Population (n=1601)

                Pediatric Population (n=287)

                P-valueb

                Age (Years)

                37 ± 11 (18–60)

                9.64 ± 0.78 (8–11)

                <.0001

                BMI

                19.7 ± 3.1 (10.1-34.2)

                14.1± 1.33 (11.46 - 25.1)

                <.0001

                Male

                38%

                50%

                0.0003

                Household Land Ownership

                47%

                54%

                0.03

                Current Betel Nut Use

                29%

                N/A

                N/A

                Current Cigarette Use

                7%

                N/A

                N/A

                B-As (μg/L)

                7 ± 5.85 (0.57 - 56.3)

                4.80 ±3.21 (0.873-21.0)

                <.0001

                U-As (μg/L)

                90.7 ± 104 (1–1138)

                78.2 ± 72.5 (6–461)

                0.01

                Urinary Creatinine (mg/dL)

                48 ± 38.3 (3.7 - 338.8)

                35.0 ± 24.2 (4.9-144.9)

                <.0001

                Water As (μg/L)

                52.0 ± 73.0 (0.1 - 700.0)

                43.6 ± 74.0 (3.0 - 464.0)

                0.0702

                Urinary As per gram Creatinine (μgAs/g Cre)

                226 ± 257 (10.0 - 4135)

                247 ± 185 (29.8 - 1265)

                0.1072

                Blood Se (μg/L)

                127 ± 20.5 (59.5-222)

                105±17.2 (64.1-174)

                <.0001

                Baseline Plasma Folate (nmol/L)

                N/A

                13.0 ± 5.37 (4.05 - 32.9)

                N/A

                Baseline Plasma B12 (nmol/L)

                N/A

                279.0 ± 142 (34.5 - 819)

                N/A

                a Urinary Arsenic (U-As) and Blood Arsenic (B-As) b P-values were calculated using a chi-square test for categorical variables and a 2 sample t-test for continuous variables.

                Table 2

                Spearman correlation coefficients for blood Se versus outcome and demographic variables a

                 

                Blood Se

                 

                Adult Population

                P-value

                Child Population

                P-value

                U-As

                0.006

                0.82

                −0.1

                0.10

                Urinary Creatinine

                0.09

                0.0006

                0.05

                0.37

                Urinary As per gram Cr

                −0.08

                0.001

                −0.20

                0.001

                B-As

                0.03

                0.31

                −0.13

                0.02

                Plasma Folate

                N/A

                N/A

                −0.09

                0.12

                Plasma B12

                N/A

                N/A

                0.18

                0.002

                Age

                −0.10

                <0.0001

                −0.13

                0.02

                BMI

                0.10

                <0.0001

                0.09

                0.14

                Sex

                0.12

                <0.0001

                0.04

                0.65

                a. Urinary Arsenic (U-As) and Blood Arsenic (B-As).

                In the linear regression model presented in Table 3, the parameter estimates are the change in the mean concentrations of the outcome variables associated with a one unit increase in blood Se with and without adjusting for sex, BMI, current betel nut use, and urinary creatinine (when applicable). A statistically significant inverse association was found between blood Se concentrations and total urinary As concentrations in both the unadjusted and adjusted models. However, there was not a statistically significant association found between blood Se and As.
                Table 3

                Estimated parameters and 95% confidence intervals for the association between blood Se (μg/L) (continuous variable) and urinary and blood As concentrations a

                Outcome variables

                (95% CI)

                 

                (95% CI)

                 

                Adult Population (n=1601)

                Unadjusted covariates

                p-value

                Adjusted covariates b

                p-value

                Log Total

                −0.003 (−0.005, -0.0009)

                0.005

                −0.002 (−0.004, -0.00003)

                0.047

                U-As (μg/L)

                Log Total

                0.001(−0.0007, 0.003)

                0.25

                0.001 (−0.0007, 0.003)

                0.24

                B-As (μg/L)

                Pedatric Population (n=287)

                Unadjusted covariates

                p-value

                Adjusted covariates c

                p-value

                Log Total

                −0.006 (−0.01, -0.002)

                0.006

                −0.006 (−0.01, -0.001)

                0.01

                U-As (μg/L)

                Log Total

                −0.004 (−0.008, -0.00002)

                0.002

                −0.004 (−0.009, -0.0001)

                0.04

                B-As(μg/L)

                    

                a Blood Arsenic (B-As) and Urinary Arsenic (U-As) b Adjusted for age, sex, BMI, current betel nut use, and urinary creatinine (log) for the outcome of urinary arsenic c Adjusted for sex, BMI, plasma folate (log), plasma B12 (log), and urinary creatinine (log) for the outcome of urinary arsenic.

                Adjusted mean values of total blood and urinary As by blood Se quintile are presented in Table 4. Decreasing urinary As concentrations were observed with increasing quintiles of blood Se with a threshold effect for both outcome variables after the second quintile. There was no trend observed for blood As with increasing quintiles of blood Se.
                Table 4

                Adjusted mean (95% CI) of outcome variables by blood Se quintile in the adult population(n=1601) a

                 

                Se category [μg/L; mean(range)]a

                 

                1

                2

                3

                4

                5

                Adult Population

                59.5 - 109.6 (n=320)

                109.7-120.3 (n=320)

                120.4-130.2 (n=321)

                130.3-143.7 (n=319)

                143.8-221.97 (n=321)

                Total U-As (μg/L)

                63.7(58.3-68.9)

                52.1(47.7-56.8)

                56.4(51.7-61.5)

                58.2(53.3-63.5)

                53.0 (48.5-57.9)

                Total B-As (μg/L)

                5.5(5.1-6.0)

                5.0 (4.6-5.4)

                5.4 (5.0-5.8)

                5.5 (5.1-5.9)

                5.5(5.1-5.9)

                a These are geometric means. B-As is for blood arsenic and U-As is for urinary arsenic. Adjusted for age, sex, BMI, ever smoking, and current betel nut, and urinary creatinine (log) for the outcome of urinary arsenic.

                Child baseline data

                Population characteristics for the 287 child study participants are presented in Table 1. The water As exposure in this population was also low to moderate. The mean water As concentration was 43.6 μg/L. Fifty percent of participants were female and household landownership was 54%. The mean age of the children enrolled in the study was 9.64 years, and the mean BMI was 14.1. The mean blood and urinary As concentrations were 4.8 μg/L and 78 μg/L, respectively. Using Spearman correlation coefficients, blood Se was significantly associated with urinary As per gram Cr (r =−0.20, p < 0.05), blood As (r = −0.13, p<0.05), plasma B12 (r = 0.18, p < 0.05), and age (r = −0.13, p<0.05) (Table 2).

                The parameter estimates in Table 3 for the linear regression models represent the change in the mean concentration of the outcome variables associated with a one unit increase in blood Se with and without adjusting for sex, BMI, plasma folate (log), plasma B12 (log), and urinary Cr (when applicable). A statistically significant inverse association was found between blood Se and urinary and blood As in the adjusted and unadjusted models.

                The adjusted mean values of total blood and urinary As by Se quintile are presented in Table 5. In the pediatric population, decreasing urinary and blood As concentrations were observed with increasing quintiles of blood Se with the suggestion of a threshold effect for both outcome variables after the second quintile.
                Table 5

                Adjusted mean (95% CI) of outcome variables by blood Se quintile (n=287) in child population a

                 

                Se category [μg/L; mean(range)]a

                 

                1

                2

                3

                4

                5

                Pediatric Population

                64.1 - 90.4

                90.5-99.4

                99.5-109.6

                109.6-119.6

                119.7-173.6

                (n=55)

                (n=60)

                (n=56)

                (n=57)

                (n=59)

                Total U-As (μg/L)

                65.8 (55.2, 78.3)

                60.8 (51.5, 71.8)

                52.5 (44.2, 62.3)

                48.6 (41.0, 57.7)

                50.7 (42.8, 60.0)

                Total B-As (μg/L)

                4.6 (3.9, 5.4)

                4.2 (3.6, 4.9)

                3.8 (3.2, 4.4)

                3.6 (3.1, 4.2)

                3.7 (3.2, 4.4)

                a These are geometric means. B-As is for blood arsenic and U-As is for urinary arsenic. Adjusted for sex, BMI, plasma folate (log), plasma B12(log), and urinary creatinine (log) for the outcome of urinary arsenic.

                Discussion

                To our knowledge, this is the first study evaluating the relationship between As and blood Se in children. In this cross-sectional study of 1601 adults and 287 children we found that blood Se is inversely associated with urinary As concentrations after adjustment for age, sex, BMI, plasma folate and B12 (in children), and ever smoking and current betel nut use (in adults). In addition, blood Se and As were found to be inversely associated in the pediatric population. These findings are consistent with our original study hypothesis.

                The statistically significant association found between blood Se and urinary and blood As are intriguing given that these study populations have low to moderate As exposure. In Pilsner et al., where a statistically significant association was found between both urinary and blood As and plasma Se, the mean water As exposure was 113.6 μg/L [29]. This was more than twice that in our present study. Chen et al. also found a statistically significant association between urinary As and blood Se As at mean water As concentrations of 101.8 μg/L [30]. This finding suggests that even at As concentrations lower than previously reported there exists an inverse relationship between As and Se.

                Urinary creatinine which is influenced by the dietary intake of creatine and muscle mass was significantly lower in children versus adults (p-value < .0001). This is consistent with previous evaluations in the study area [29, 42]. Urinary As was also found to be significantly lower in the pediatric population (p-value < .01). However after adjustment for hydration status using urinary creatinine there was no statistically significant difference observed in urinary As concentrations between the two study populations.

                The blood Se concentrations were found to be significantly lower in the pediatric versus adult population (p-value < .0001). This is consistent with previous studies that have observed increasing Se status with age [4345]. BMI was found to be positively associated with blood Se in children. This finding is likely attributable to a better overall diet in those children with a higher BMI.

                The observed blood Se concentrations (59.5-222 μg/L) in the present study are not particularly low when compared to values globally which range from a mean blood Se of 62 μg/L in Finland to 229 μg/L reported in the central states of the United States [46]. Previous studies of children have reported mean values of blood Se ranging from 42 μg/L to 120 μg/L [47]. Thus, this region of Bangladesh does not appear to be associated with Se deficiency.

                There is a growing body of scientific literature suggesting a potential elimination route of As through the formation of Se-As conjugate(GS2AsSe) in the liver which is excreted into bile [28, 48]. This conjugate thus far has only been identified in animals models [27, 49]. In our current evaluation of an adult population, we observed a statistically significant association between blood Se and total urinary As, however no such association was found for blood As. This result is consistent with findings in Chen et al. [30]. In contrast, Pilsner et al. found a statistically significant association between Se status and total blood and urinary As concentrations in an adult population, however plasma rather than whole blood Se was used as the marker of nutritional status [29]. In our pediatric population, we observed a statistically significant inverse association between blood Se and both total urinary and blood As. The reason for the statistically significant association between blood Se and As observed in children but not adults is unclear and warrants future investigation.

                For the adult population the greatest reduction in mean adjusted urinary As concentrations occurred from the first to the second quintile, while for the pediatric population this occurred from the second to the third quintile. The blood Se cutoff for both was at approximately 110 μg/L. These finding suggest a threshold effect in both adult and pediatric populations after which the blood Se concentration has little effect on urinary As concentrations. A similar threshold effect was observed in Pilsner et al. [29].

                A limitation of this study was that we did not measure urinary metabolites of As in our adult and pediatric study population. Pilsner et al. found that a higher proportion of dimethylarsinic acid (DMA(III) and DMA(V)), was positively associated with blood Se [29]. This suggests the possibility that higher blood Se is associated with increased inorganic As metabolism.

                Conclusions

                The results of this study indicate a statistically significant inverse relationship between blood Se and urinary As concentrations in both adult and pediatric populations in rural Bangladesh. In addition, there appears to be a statistically significant inverse relationship between blood Se and As in children. These findings suggest the potential for the hypothesized elimination mechanism for As, possibly via the the Se-As conjugate (GS2AsSe). However, because we conducted a cross-sectional analysis we cannot determine if this relationship is causal. Laboratory based studies are needed to elucidate if the Se-As conjugate (GS2AsSe) is an important route of As elimination in humans. Further research is needed to investigate nutritional influences of Se on As metabolism in pediatric populations.

                Abbreviations

                As: 

                Arsenic

                BMI: 

                Body Mass Index

                Cr: 

                Urinary creatinine

                GS: 

                Glutathione

                GPx: 

                Glutathione peroxidase

                HEALS: 

                Health Effects of Arsenic Longitudinal Study

                ICP-MS: 

                Inductively Coupled Plasma Mass Spectrometry

                Mn: 

                Manganese

                Se: 

                Selenium

                WHO: 

                World Health Organization.

                Declarations

                Acknowledgements

                This research was supported by US National Institutes of Health grant (Bethesda, Maryland) P42 ES10349, P30ES09089. We would like to thank the staff at the Columbia University Arsenic & Health Research in Bangladesh office for their tireless support: Dr. Tariqul Islam, Khaled Hasan, Sawkat Haiat Sarwar, Dr. Rakibuz Zaman, Dr. Mahfuzar Rahman, Dr Abu Bakar Siddique, Golam Sarwar, Nur-E-Azam Sarwar, Shariful Islam Khan, Lisma Akhter, Shawkat Jahangir, Shahid Ahmed Sorwar, Nahid Farjana, Tahmina Akter, Jesmin Neher, Ershad Bin Ahmed, Jismin Neher, Jakir Hossain Mir, Kalpana Rani Das, and Abul Kalam Azad.

                Authors’ Affiliations

                (1)
                Department of International Health, Program in Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health
                (2)
                Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University
                (3)
                Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University
                (4)
                Department of Biostatistics, Mailman School of Public Health, Columbia University
                (5)
                University of Chicago Arsenic & Health Research in Bangladesh
                (6)
                Department of Health Studies, The University of Chicago Biological Sciences

                References

                1. Ahmed MF, Ahuja S, Alauddin M, Hug SJ, Lloyd JR, Pfaff A, Pichler T, Saltikov C, Stute M, van Geen A: Epidemiology. Ensuring safe drinking water in bangladesh. Science 2006, 314:1687–1688.View Article
                2. Verret WJ, Chen Y, Ahmed A, Islam T, Parvez F, Kibriya MG, Graziano JH, Ahsan H: A randomized, double-blind placebo-controlled trial evaluating the effects of vitamin E and selenium on arsenic-induced skin lesions in bangladesh. J Occup Environ Med 2005, 47:1026–1035.View Article
                3. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH: Fifty-year study of lung and bladder cancer mortality in chile related to arsenic in drinking water. J Natl Cancer Inst 2007, 99:920–928.View Article
                4. Chen Y, Ahsan H: Cancer burden from arsenic in drinking water in bangladesh. Am J Public Health 2004, 94:741–744.View Article
                5. Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ: Risk of internal cancers from arsenic in drinking water. Environ Health Perspect 2000, 108:655–661.View Article
                6. Calderon J, Navarro ME, Jimenez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Leyva I, Borja-Aburto V, Diaz-Barriga F: Exposure to arsenic and lead and neuropsychological development in mexican children. Environ Res 2001, 85:69–76.View Article
                7. Wasserman GA, Liu X, Parvez F, Factor-Litvak P, Ahsan H, Levy D, Kline J, van Geen A, Mey J, Slavkovich V, et al.: Arsenic and manganese exposure and children's intellectual function. Neurotoxicology 2011, 32:450–457.View Article
                8. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, Parvez F, van Geen A, Ahsan H: Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in bangladesh: a population-based, cross-sectional study. Am J Epidemiol 2007, 165:541–552.View Article
                9. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, Argos M, Islam T, Ahmed A, Rakibuz-Zaman M, et al.: Arsenic exposure from drinking water and mortality from cardiovascular disease in bangladesh: prospective cohort study. BMJ 2011, 342:d2431.View Article
                10. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, Mitra S, Santra A, Lahiri S, Das S, et al.: Arsenic in drinking water and skin lesions: dose–response data from west bengal, india. Epidemiology 2003, 14:174–182.
                11. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, Hussain I, Momotaj H, Levy D, Cheng Z, Slavkovich V, et al.: Arsenic exposure from drinking water and risk of premalignant skin lesions in bangladesh: baseline results from the health effects of arsenic longitudinal study. Am J Epidemiol 2006, 163:1138–1148.View Article
                12. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, van Geen A, Slavkovich V, Loiacono NJ, Levy D, et al.: Water arsenic exposure and intellectual function in 6-year-old children in araihazar, bangladesh. Environ Health Perspect 2007, 115:285–289.View Article
                13. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, Slavkovich V, LoIacono NJ, Cheng Z, Hussain I, et al.: Water arsenic exposure and children's intellectual function in araihazar, bangladesh. Environ Health Perspect 2004, 112:1329–1333.View Article
                14. Whanger P: Selenocompounds in plants and animals and their biological significance. J Am Coll Nutr 2002, 21:223–232.View Article
                15. Zeng H, Uthus EO, Combs GF: Mechanistic aspects of the interaction between selenium and arsenic. J Inorg Biochem 2005, 99:1269–1274.View Article
                16. Rayman MP: The importance of selenium to human health. Lancet 2000, 356:233–241.View Article
                17. Tapiero H, Townsend D, Tew K: The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 2003, 57:134–144.View Article
                18. Gromadzińska J, Reszka E, Bruzelius K, Wąsowicz W, Åkesson B: Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur J Nutr 2008, 47:29–50.View Article
                19. Basic Information about Selenium in Drinking Water http://​water.​epa.​gov/​drink/​contaminants/​basicinformation​/​selenium.​cfm
                20. Fan A, Kizer K: Selenium. Nutritional, toxicologic, and clinical aspects. West J Med 1990, 153:160.
                21. Rayman MP: Selenium and human health. The Lancet 2012, 379:1256–1268.View Article
                22. Johnson CC, Fordyce FM, Rayman MP: Symposium on “geographical and geological influences on nutrition”: factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc Nutr Soc 2010, 69:119–132.View Article
                23. Moxon AL, DuBois KP: The influence of arsenic and certain other elements on the toxicity of seleniferous grains three figures. J Nutr 1939, 18:447–457.
                24. Levander OA: Metabolic interrelationships between arsenic and selenium. Environ Health Perspect 1977, 19:159.View Article
                25. Levander O, Argrett L: Effects of arsenic, mercury, thallium, and lead on selenium metabolism in rats. Toxicol Appl Pharmacol 1969, 14:308–314.View Article
                26. Levander O, Baumann C: Selenium metabolism: VI. Effect of arsenic on the excretion of selenium in the bile. Toxicol Appl Pharmacol 1966, 9:106–115.View Article
                27. Gailer J, George GN, Pickering IJ, Prince RC, Ringwaid SC, Pemberton JE, Glass RS, Younis HS, DeYoung DW, Aposhian HV: A metabolic link between arsenite and selenite: the seleno-bis (S-glutathionyl) arsinium ion. J Am Chem Soc 2000, 122:4637–4639.View Article
                28. Berry J, Galle P: Selenium-arsenic interaction in renal cells: role of lysosomes. Electron microprobe study. J Submicrosc Cytol Pathol 1994, 26:203.
                29. Pilsner JR, Hall MN, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Graziano JH, Gamble MV: Associations of plasma selenium with arsenic and genomic methylation of leukocyte DNA in bangladesh. Environ Health Perspect 2011, 119:113–118.
                30. Chen Y, Hall M, Graziano JH, Slavkovich V, van Geen A, Parvez F, Ahsan H: A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol Biomarkers Prev 2007, 16:207–213.View Article
                31. Chung JS, Haque R, Guha Mazumder D, Moore LE, Ghosh N, Samanta S, Mitra S, Hira-Smith MM, von Ehrenstein O, Basu A: Blood concentrations of methionine, selenium, beta-carotene, and other micronutrients in a case–control study of arsenic-induced skin lesions in West Bengal, India . Environmental research 2006, 101:230–237.View Article
                32. Burns FJ, Rossman T, Vega K, Uddin A, Vogt S, Lai B, Reeder RJ: Mechanism of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice. Environ Health Perspect 2008, 116:703.View Article
                33. Messarah M, Klibet F, Boumendjel A, Abdennour C, Bouzerna N, Boulakoud MS, El Feki A: Hepatoprotective role and antioxidant capacity of selenium on arsenic-induced liver injury in rats. Exp Toxicol Pathol 2012, 64:167–174.View Article
                34. Yang L, Wang W, Hou S, Peterson PJ, Williams WP: Effects of selenium supplementation on arsenism: an intervention trial in inner mongolia. Environ Geochem Health 2002, 24:359–374.View Article
                35. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, Levy D, van Geen A, Howe G, Graziano J: Health effects of arsenic longitudinal study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol 2006, 16:191–205.View Article
                36. Hall M, Chen Y, Ahsan H, Slavkovich V, van Geen A, Parvez F, Graziano J: Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology 2006, 225:225–233.View Article
                37. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, Parvez F, Graziano JH: Folate and cobalamin deficiencies and hyperhomocysteinemia in bangladesh. Am J Clin Nutr 2005, 81:1372–1377.
                38. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP: Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 1991, 37:1575–1579.
                39. Van Geen A, Cheng Z, Seddique AA, Hoque MA, Gelman A, Graziano JH, Ahsan H, Parvez F, Ahmed KM: Reliability of a commercial kit to test groundwater for arsenic in bangladesh. Environ Sci Technol 2005, 39:299–303.View Article
                40. Lindberg AL, Ekström EC, Nermell B, Rahman M, Lönnerdal B, Persson LÅ, Vahter M: Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in bangladesh. Environmental research 2008, 106:110–120.View Article
                41. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, Parvez F, Levy D, Factor-Litvak P, Graziano JH: Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in bangladesh. Environ Health Perspect 2005, 113:1683.View Article
                42. Hall MN, Liu X, Slavkovich V, Ilievski V, Pilsner JR, Alam S, Factor-Litvak P, Graziano JH, Gamble MV: Folate, cobalamin, cysteine, homocysteine, and arsenic metabolism among children in bangladesh. Environ Health Perspect 2009, 117:825–831.View Article
                43. Hatano S, Nishi Y, Usui T: Plasma selenium concentration in healthy japanese children and adults determined by flameless atomic absorption spectrophotometry. J Pediatr Gastroenterol Nutr 1984, 3:426–431.View Article
                44. Thomson CD, McLachlan SK, Parnell WR, Wilson N, Wohlers M, Scragg R, Schaaf D, Fitzgerald ED: Serum selenium concentrations and dietary selenium intake of New zealand children aged 5–14 years. Br J Nutr 2007, 97:357–364.View Article
                45. Muntau AC, Streiter M, Kappler M, Röschinger W, Schmid I, Rehnert A, Schramel P, Roscher AA: Age-related reference values for serum selenium concentrations in infants and children. Clin Chem 2002, 48:555–560.
                46. Combs GF: Selenium in global food systems. Br J Nutr 2001, 85:517–547.View Article
                47. McKenzie RL, Rea HM, Thomson C, Robinson M: Selenium concentration and glutathione peroxidase activity in blood of New zealand infants and children. Am J Clin Nutr 1978, 31:1413–1418.
                48. Gailer J: Chronic toxicity of as (III) in mammals: the role of (GS)(2) AsSe (−). Biochimie 2009, 91:1268.View Article
                49. Gailer J, George GN, Pickering IJ, Prince RC, Younis HS, Winzerling J: Biliary excretion of [(GS) 2AsSe]-after intravenous injection of rabbits with arsenite and selenate. Chem Res Toxicol 2002, 15:1466–1471.View Article

                Copyright

                © George et al.; licensee BioMed Central Ltd. 2013

                This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.